4-Bromo-3-fluoro-6-nitro-2-(tetrahydrofuran-2-yl)aniline, 98%, 1g

TERT-BUTYL 4-HYDROXY-4-(TRIFLUOROMETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 500mg

1-(2,3-dimethylphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

4-Bromopyridine, 98%, 25g

3-(N-BOC-METHYLAMINOMETHYL)AZETIDINE HCL, 95.0%, 25g

Plan phase PLPHi 20x/0.40 objectif IOS corrigé à l'infini. Distance de travail 8,80 mm

1-(4-Bromophenyl)-2-phenylethane-1,2-dione, 97.0%, 5g

2-Chloro-4-ethynylpyrimidine, 95+%, 1g

Ethyl 2-amino-3-chloro-4-methylbenzoate, 98%, 100mg

3-Acetyl-7-hydroxy-2H-chromen-2-one, 95+%, 100mg

Methyl 4-chloro-3-methoxy-5-nitrobenzenecarboxylate, 95.0%, 1g

2-Amino-4-chlorobenzamide, 95.0%, 5g

2-Methyl-5-(trifluoromethyl)aniline>98.0%(GC)(T)1g